Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes

<p>Abstract</p> <p>Background</p> <p>Treatment guidelines recommend LDL-C as the primary target of therapy in patients with hypercholesterolemia. Moreover, combination therapies with lipid-lowering drugs that have different mechanisms of action are recommended when it i...

Full description

Bibliographic Details
Main Authors:	Hanson Mary E, Le Grazie Cristina, Zaninelli Augusto, Rotella Carlo M, Gensini Gian
Format:	Article
Language:	English
Published:	BMC 2010-07-01
Series:	Lipids in Health and Disease
Online Access:	http://www.lipidworld.com/content/9/1/80

Similar Items

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)
by: Le Grazie Cristina, et al.
Published: (2010-05-01)

Simultaneous Determination of Simvastatin and Ezetimibe in Tablets by HPLC
by: D. Anantha Kumar, et al.
Published: (2009-01-01)

Simultaneous HPTLC Estimation of Simvastatin and Ezetimibe in Tablet Dosage Form
by: Bhupendra Shrestha, et al.
Published: (2010-01-01)

Role of Ezetimibe in Combination with Statins(Simvastatin and Atorvastatin) in Controlling Dyslipidemia
by: Falah H.Al-Malki, et al.
Published: (2017-03-01)

Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects
by: Kater Ana-Lucia A, et al.
Published: (2010-06-01)

The angiogenesis and functional repair effect of simvastatin and ezetimibe on diabetic mice model with hindlimb ischemia.
by: Jian-You Chen, et al.
Published: (2012)

Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
by: D. M. Aronov
Published: (2005-08-01)

Simvastatin and Ezetimibe-Loaded Nanofibers Administered Locally to Augment Bone Healing
by: Shayan Amiri, et al.
Published: (2021-01-01)

A report of successful management with simvastatin plus ezetimibe in alopecia areata
by: Javier Arellano, et al.
Published: (2020-11-01)

Physical Stability and Viscoelastic Properties of Co-Amorphous Ezetimibe/Simvastatin System
by: Justyna Knapik-Kowalczuk, et al.
Published: (2019-03-01)

Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
by: Ryan C Neal, et al.
Published: (2006-03-01)

Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men
by: Thomas Sudhop, et al.
Published: (2009-10-01)

Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia
by: André J Tremblay, et al.
Published: (2009-07-01)

Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy
by: L.M. Camargo, et al.
Published: (2014-05-01)

Simultaneous spectrophotometric determination of ezetimibe and simvastatin in pharmaceutical preparations using chemometric techniques
by: Ismail Murat Palabiyik, et al.
Published: (2008-01-01)

Development and Validation of a Derivative Spectrophotometric Method for Simultaneous Determination of Simvastatin and Ezetimibe
by: Effat Souri, et al.
Published: (2010-01-01)

Hypolipidemic and pleiotropic effects of a combination of simvastatin and ezetimibe in patients with different types of hyperlipidemia
by: A B Sumarokov, et al.
Published: (2014-12-01)

Microemulsion Liquid Chromatographic Method for Simultaneous Determination of Simvastatin and Ezetimibe in Their Combined Dosage Forms
by: Mohammed E. A. Hammouda, et al.
Published: (2013-01-01)

The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatins⃞
by: Dawn E. Telford, et al.
Published: (2007-03-01)

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
by: Farnier Michel, et al.
Published: (2011-11-01)

Är simvastatin i kombination med ezetimib mer effektivt för att förbättra lipidstatus hos patienter med hyperkolestrolemi än simvastatin i monoterapi?
by: Nilsson, Johanna
Published: (2021)

Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia
by: N. E. Artamoshina, et al.
Published: (2012-12-01)

Evidence from a randomized trial that simvastatin, but not ezetimibe, upregulates circulating PCSK9 levels.
by: Heiner K Berthold, et al.
Published: (2013-01-01)

Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review
by: Naderi S, et al.
Published: (2012-12-01)

VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate
by: Michel Farnier, et al.
Published: (2008-12-01)

Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial[S]
by: L. Jakulj, et al.
Published: (2010-04-01)

Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Geannyne Villegas-Rivera, et al.
Published: (2015-01-01)

Simvastatin-Loaded Nanomicelles Enhance the Osteogenic Effect of Simvastatin
by: Xianling Feng, et al.
Published: (2020-01-01)

Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation
by: Minyoung Oh, et al.
Published: (2019-08-01)

Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
by: Hanson Mary E, et al.
Published: (2010-11-01)

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01)

Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heart
by: Ankur Rohilla, et al.
Published: (2012-01-01)

Pleiotrope Effekte der Therapie mit Simvastatin und Ezetimib auf die Endothelfunktion in LDL-Rezeptor-Knockout Mäusen
by: Miller, Nadja Katrin
Published: (2011)

Enzymatic Synthesis of Simvastatin
by: Chuang , Shu-Ju, et al.
Published: (2001)

Development of simvastatin osteo-inductive biomaterial and study of the osteogenesis molecular mechanism of simvastatin
by: I-Chun Tai, et al.
Published: (2015)

13. THE LONG-TERM EFFECT BETWEEN CO-ADMINISTRATION OF SIMVASTATIN AND EZETIMIBE AND ATORVASTATIN ON CENTRAL PULSE WAVE VELOCITY IN ADULTS WITH HYPERCHOLESTEROLEMIA
by: Young Soo Lee, et al.
Published: (2009-10-01)

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
by: Foody JM, et al.
Published: (2013-11-01)

09.01 EZETIMIBE AND SIMVASTATIN BOTH REDUCE INFLAMMATION, DISEASE ACTIVITY, AORTIC STIFFNESS AND IMPROVE ENDOTHELIAL FUNCTION IN RHEUMATOID ARTHRITIS
by: K.M. Maki-Petaja*, et al.
Published: (2007-06-01)

Myopathy with Concurrent Tadalafil and Simvastatin
by: Maria Pia Gargante, et al.
Published: (2009-01-01)

ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2013-12-01)